Core Viewpoint - The company, Qianyin Gaoke, reported a steady growth in revenue and net profit for 2024 and Q1 2025, driven by increased sales in its seed business, particularly in rice and corn [2][3][4]. Financial Performance - In 2024, the company achieved a revenue of 4.709 billion yuan, a year-on-year increase of 14.77%, with a net profit of 114 million yuan [2]. - For Q1 2025, the company reported a revenue of 835 million yuan, up 24.13% year-on-year, with a net profit of 2.197 million yuan [2]. - The company aims to reach a revenue target of 5 billion yuan and a net profit of 300 million yuan for 2025 [2]. Seed Business Overview - The rice seed sales revenue reached 1.858 billion yuan in 2024, a growth of 5.67%, with a total sales volume of 216 million kilograms, up nearly 7% [3]. - The corn seed segment generated a revenue of 589 million yuan in 2024, reflecting a 20.43% increase, with a gross margin of 33.15% [4]. Innovation and Patents - The company received a national patent for a method of creating broadly resistant transgenic corn, marking a significant advancement in disease-resistant crop development [5]. - In 2024, 59 new rice varieties and 13 new corn varieties were approved, enhancing the company's competitive edge in the market [3][4]. International Market Development - In 2024, the company exported 19.3735 million kilograms of seeds, a 74.80% increase year-on-year, generating an overseas revenue of 492 million yuan, up 72.39% [6][7]. - The company is actively pursuing international breeding collaborations to expand its global market presence [7]. Audit and Financial Health - The company maintains that its accounts receivable and inventory valuations are accurate, and it plans to take measures to recover outstanding receivables over the next two years [8]. - The Q1 2025 report indicated a debt ratio of 62.94%, with a gross margin of 13.48% [8].

Core Viewpoint - The company reported a revenue increase of 14.77% in 2024, but net profit decreased by 58.23% due to various factors including declining seed gross margins and increased operating expenses [1][5][6]. Financial Performance - In 2024, the company achieved a revenue of 4.709 billion yuan, up from the previous year, primarily driven by increased seed exports and domestic corn seed sales [5][6]. - The sales revenue from rice seeds was 1.858 billion yuan, a year-on-year increase of 5.67%, while corn seed sales reached 589 million yuan, growing by 20.43% [5]. - The fastest growth came from order grain and silage feed, which generated 1.191 billion yuan, marking a 44.22% increase [5]. Profitability Issues - The company reported a net profit of 114 million yuan, down 58.23% from the previous year, resulting in a decrease of 160 million yuan [1][6]. - The decline in net profit was attributed to three main factors: reduced gross margins in seed business, increased R&D and operating expenses, and significant impairment losses [6][7]. Impairment Losses - The total impairment losses for the year amounted to 238 million yuan, which significantly impacted the net profit [6][7]. - Specific impairment losses included 85.6686 million yuan for accounts receivable, 21.6848 million yuan for other receivables, and 80.7006 million yuan for inventory [6][7]. Audit Concerns - The company's financial statements received a qualified opinion from the auditing firm due to two key issues: the existence and accuracy of certain receivables and the valuation of inventory [7][8]. - The first issue involved accounts receivable related to grain sales, where the company could not confirm the existence and accuracy of 32.7759 million yuan in receivables [7][8]. - The second issue pertained to the valuation of inventory, where the company failed to provide sufficient evidence to support its sales forecasts for corn seed inventory [8][9]. Management Response - The company plans to actively pursue the collection of receivables from three grain sales companies and aims to recover the amounts within two years [9]. - For the corn seed inventory, the company intends to implement various measures to ensure sales within the next two years [9].

证券代码：300087 证券简称：荃银高科 公告编号：2025-024 安徽荃银高科种业股份有限公司 关于第二期员工持股计划第二个解锁期 业绩考核目标未达成的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 公司于2019年3月11日至2019年11月19日回购股份18,134,236 股。2020 年 12 月 16 日，公司将回购专用证券账户中的 9,170,000 股 股票非交易过户至"安徽荃银高科种业股份有限公司—第一期员工持 股计划"专用证券账户。2022 年 11 月 14 日，公司将回购专用证券 账户中剩余的 8,964,236 股非交易过户至"安徽荃银高科种业股份有 限公司—第二期员工持股计划"专用证券账户。 根据第二期员工持股计划（草案），本员工持股计划的存续期为 60 个月，自公司公告标的股票过户至员工持股计划名下之日起算。 存续期的前 12 个月为锁定期，锁定期届满后，股票分三批解锁，自 公司分别公告 2023 年年度报告、2024 年年度报告、2025 年年度报告 后解锁本期员工持股计划总数的 50%、30%、20%。 第二期员工持 ...

Financial Performance - In 2024, the company achieved a revenue of 4.709 billion CNY, a year-on-year increase of 14.77% [1] - The net profit attributable to shareholders was 114 million CNY, with seed sales and volumes steadily increasing [1] - In Q1 2025, revenue reached 835 million CNY, up 24.13% compared to the same period last year, with a net profit of 2.197 million CNY [1] Rice Business - Rice seed sales revenue was 1.858 billion CNY, a growth of 5.67% [2] - The company operates in 17 provinces, establishing a comprehensive sales network [2] - A patented method for hybrid rice seed production has been authorized, enhancing production efficiency and reducing costs [2] Corn Business - Corn seed sales revenue reached 589 million CNY, with a year-on-year growth of 20.43% and a gross margin of 33.15% [3] - The company has developed 19 hybrid corn varieties approved at the national level and 13 at the provincial level [3] - The company aims to rank among the top three in corn seed sales by the end of the 14th Five-Year Plan [3] International Market Development - In 2024, overseas sales of various agricultural seeds reached 19.3735 million kg, a 74.80% increase year-on-year, generating 492 million CNY in revenue, up 72.39% [4] - The company has successfully registered 24 hybrid rice and corn varieties in Southeast Asia and Africa [4] - International breeding collaborations are being pursued to enhance global competitiveness [4] Audit Opinions - The company believes the book value of receivables from liquor grain sales is accurate, and the methods for revenue recognition and bad debt provision are reasonable [5] - Measures will be taken to recover receivables within the next two years [5] - Strategies are in place to ensure the sale of corn seed inventory over the next two years [5]

Core Insights - The company reported a revenue of 4.709 billion yuan for 2024, marking a year-on-year increase of 14.77% and a net profit of 114 million yuan, driven by steady growth in seed sales and exports [1] - The company achieved a total seed sales volume of 21,620.91 million kilograms, reflecting a year-on-year growth of 6.81%, with significant increases in rice and corn sales [1] - The company has enhanced its breeding innovation capabilities, with 59 new rice varieties and 19 hybrid corn varieties passing national certification in 2024 [1] Group 1 - The company has optimized its business structure by establishing dedicated divisions for rice and corn, exploring a new marketing model that integrates "advantage products + services" [2] - The company has expanded its sales network across 17 provinces and cities in China, strengthening market control and combating infringement [2] - The company’s overseas sales reached 19,373.48 tons, a 74.80% increase year-on-year, with overseas revenue of 492 million yuan, up 72.39% [2] Group 2 - The company reported a revenue of 835.32 million yuan for Q1 2025, a 24.13% increase compared to the same period last year, attributed to increased seed exports and grain orders [3] - The net profit for Q1 2025 was 2.197 million yuan, indicating positive growth in the company's financial performance [3]

安徽荃银高科种业股份有限公司 董事会关于 2024 年度财务审计报告保留意见涉及事项的专项说明 毕马威华振会计师事务所（特殊普通合伙）（以下简称"毕马威"）对安徽 荃银高科种业股份有限公司（以下简称"公司"或"荃银高科"）2024 年度财 务报告出具了保留意见的审计报告。 一、审计报告中形成保留意见的基础 （一）销售酒粮业务所产生的应收款项的存在性和账面价值的准确性 如财务报表附注五、4 和附注五、6 所述，于 2024 年 12 月 31 日，荃银高科 合并资产负债表的应收账款中包括子公司四川荃银生物有限责任公司（以下简称 "四川荃银生物" ）与三家酒厂因酒粮销售相关的交易而确认的应收账款人民 币 3,277.59 万元（2023 年 12 月 31 日：人民币 3,277.59 万元），坏账准备余额 为人民币 816.12 万元（2023 年 12 月 31 日：人民币 65.55 万元），账面价值为 人民币 2,461.47 万元（2023 年 12 月 31 日：人民币 3,212.04 万元），以及与贵 州某公司的其他应收款原值人民币 688.29 万元（2023 年 12 月 31 日：人民币 6 ...

安徽荃银高科种业股份有限公司 关于中化集团财务有限责任公司 2024 年度风险评估报告 根据中国证券监督管理委员会、深圳证券交易所的相关要求，安徽荃银高科 种业股份有限公司（以下简称"本公司"）通过查验中化集团财务有限责任公司 （以下简称"中化财务公司"或"公司"）《金融许可证》《营业执照》等证件 资料，并审阅了中化财务公司验资及审计报告，对中化财务公司的经营资质、业 务和风险状况进行了评估，现将有关风险评估情况报告如下： 一、中化财务公司基本情况 （一）企业历史沿革、注册地、组织形式和总部地址 中化集团财务有限责任公司系经原中国银行保险监督管理委员会（现为国家 金融监督管理总局）批准，由中国中化集团有限公司（以下简称"中化集团"） 出资，在北京成立的有限责任公司。公司于2008年6月4日在国家市场监督管理总 局办理了工商登记，企业法人营业执照注册号：100000000041669；法定代表人： 陈国钢；注册资本600,000万元；注册地：北京市西城区复兴门内大街28号凯晨 世贸中心中座F3层；总部地址：北京西城区。本公司于2023年8月8日变更营业执 照，法定代表人变更为夏宇。社会统一信用代码证号为9111 ...

证券代码：300087 证券简称：荃银高科 公告编号：2025-017 安徽荃银高科种业股份有限公司 关于向金融机构申请综合授信的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 安徽荃银高科种业股份有限公司（以下简称"公司"）于 2025 年 4 月 27 日-29 日召开第五届董事会第二十三次会议，审议通过《关于 向金融机构申请综合授信的议案》。现将相关事项公告如下： 一、申请综合授信的主要内容 （一）申请原因 公司目前已成为拥有 24 家控股子公司的集团公司，随着业务规 模的不断扩大及业务量的持续增加，母子公司日常运营需要大量的流 动资金。为满足公司及子公司生产经营的资金需求，进一步补充流动 性同时发挥多家银行比较优势，降低资金成本，公司拟向金融机构申 请授信。 （二）授信类型 申请授信额度 5 亿元，包括但不限于流动资金贷款、专项贷款、 保理融资、并购贷款、票据承兑、票据贴现、商票融资、开立保函、 远期国内信用证及押汇、远期信用证及押汇、进口代付、减免保证金 外汇交易、出口押汇、出口商业发票贴现等。 （三）授信方式 采用信用等方式。 （四）授信期限 ...

一、2024年年审会计师事务所基本情况 （一）会计师事务所基本情况 毕马威华振会计师事务所（特殊普通合伙）成立于1992年8月18日，2012年7月5日获 财政部批准转制为特殊普通合伙的合伙制企业，2012 年 7 月 10 日取得工商营业执照，2012 年 8 月 1 日正式运营。总部位于北京，注册地址为北京市东城区东长安街1号东方广场东2 座办公楼8层。2024年度末，毕马威华振有合伙人241人，注册会计师1,309人，其中签署过 证券服务业务审计报告的注册会计师超过300人。毕马威华振 2023 年上市公司年报审计客 户家数为 98 家，上市公司财务报表审计收费总额约为人民币 5.38 亿元。 安徽荃银高科种业股份有限公司 董事会审计委员会对会计师事务所 2024年度履职情况评估及履行监督职责情况报告 根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司治理准则》《 国有企业、上市公司选聘会计师事务所管理办法》《深圳证券交易所上市公司自律监管指 引第2号——创业板上市公司规范运作》和安徽荃银高科种业股份有限公司（以下简称"公 司"）的《公司章程》《董事会审计委员会工作细则》等规定和要求，董事会 ...

对安徽荃银高科种业股份有限公司 募集资金 2024 年度存放与实际使用情况专项报告的鉴证报告 KPMG Huazhen LLP, a People's Republic of China partnership and a member firm of the KPMG global organisation of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. KPMG Huazhen LLP 8th Floor, KPMG Tower Oriental Plaza 1 East Chang An Avenue Beijing 100738 China Telephone +86 (10) 8508 5000 Fax +86 (10) 8518 5111 Internet kpmg.com/cn 毕马威华振会计师事务所 (特殊普通合伙) 中国北京 东长安街 1 号 东方广场毕马威大楼 8 层 邮政编码:100738 电话 + ...